Department of Psychiatry, Washington University, St. Louis, MO, 63110, USA.
NeuroGenomics and Informatics, Washington University, St. Louis, MO, 63110, USA.
Acta Neuropathol Commun. 2023 Apr 26;11(1):68. doi: 10.1186/s40478-023-01563-4.
Amyloid PET imaging has been crucial for detecting the accumulation of amyloid beta (Aβ) deposits in the brain and to study Alzheimer's disease (AD). We performed a genome-wide association study on the largest collection of amyloid imaging data (N = 13,409) to date, across multiple ethnicities from multicenter cohorts to identify variants associated with brain amyloidosis and AD risk. We found a strong APOE signal on chr19q.13.32 (top SNP: APOE ɛ4; rs429358; β = 0.35, SE = 0.01, P = 6.2 × 10, MAF = 0.19), driven by APOE ɛ4, and five additional novel associations (APOE ε2/rs7412; rs73052335/rs5117, rs1081105, rs438811, and rs4420638) independent of APOE ɛ4. APOE ɛ4 and ε2 showed race specific effect with stronger association in Non-Hispanic Whites, with the lowest association in Asians. Besides the APOE, we also identified three other genome-wide loci: ABCA7 (rs12151021/chr19p.13.3; β = 0.07, SE = 0.01, P = 9.2 × 10, MAF = 0.32), CR1 (rs6656401/chr1q.32.2; β = 0.1, SE = 0.02, P = 2.4 × 10, MAF = 0.18) and FERMT2 locus (rs117834516/chr14q.22.1; β = 0.16, SE = 0.03, P = 1.1 × 10, MAF = 0.06) that all colocalized with AD risk. Sex-stratified analyses identified two novel female-specific signals on chr5p.14.1 (rs529007143, β = 0.79, SE = 0.14, P = 1.4 × 10, MAF = 0.006, sex-interaction P = 9.8 × 10) and chr11p.15.2 (rs192346166, β = 0.94, SE = 0.17, P = 3.7 × 10, MAF = 0.004, sex-interaction P = 1.3 × 10). We also demonstrated that the overall genetic architecture of brain amyloidosis overlaps with that of AD, Frontotemporal Dementia, stroke, and brain structure-related complex human traits. Overall, our results have important implications when estimating the individual risk to a population level, as race and sex will needed to be taken into account. This may affect participant selection for future clinical trials and therapies.
淀粉样蛋白 PET 成像对于检测大脑中淀粉样 beta(Aβ)沉积的积累以及研究阿尔茨海默病(AD)至关重要。我们对迄今为止最大的淀粉样蛋白成像数据(N=13409)进行了全基因组关联研究,涉及来自多中心队列的多个种族,以确定与脑淀粉样变和 AD 风险相关的变体。我们在 19q13.32 上发现了一个强烈的 APOE 信号(顶级 SNP:APOE ε4;rs429358;β=0.35,SE=0.01,P=6.2×10,MAF=0.19),这主要由 APOE ε4 驱动,还有五个额外的新关联(APOE ε2/rs7412;rs73052335/rs5117、rs1081105、rs438811 和 rs4420638)与 APOE ε4 无关。APOE ε4 和 ε2 表现出种族特异性效应,在非西班牙裔白人中关联性更强,而在亚洲人中关联性最低。除了 APOE 之外,我们还确定了三个其他全基因组位点:ABCA7(rs12151021/chr19p.13.3;β=0.07,SE=0.01,P=9.2×10,MAF=0.32)、CR1(rs6656401/chr1q.32.2;β=0.1,SE=0.02,P=2.4×10,MAF=0.18)和 FERMT2 基因座(rs117834516/chr14q.22.1;β=0.16,SE=0.03,P=1.1×10,MAF=0.06),这些都与 AD 风险相关。性别分层分析在 chr5p.14.1(rs529007143,β=0.79,SE=0.14,P=1.4×10,MAF=0.006,性别交互作用 P=9.8×10)和 chr11p.15.2(rs192346166,β=0.94,SE=0.17,P=3.7×10,MAF=0.004,性别交互作用 P=1.3×10)上发现了两个新的女性特异性信号。我们还表明,脑淀粉样蛋白的总体遗传结构与 AD、额颞叶痴呆、中风和与大脑结构相关的复杂人类特征重叠。总的来说,我们的研究结果具有重要意义,因为需要考虑种族和性别来估计个体在人群中的风险,这可能会影响未来临床试验和治疗的参与者选择。